BEVERLY, Mass.—Michael McGee has succeeded Mark Ostwald as CEO of Freudenberg Medical, a division of Weinheim, Germany-based Freudenberg Group.
McGee, the former chief operating officer who joined Freudenberg Medical in 2022, took the top post Jan. 1.
"Michael has already demonstrated his ability to drive results and success," said Mohsen Sohi, Freudenberg Group CEO and speaker of the Management Board. "The Board of Management is confident that under his leadership, Freudenberg Medical will continue to grow, innovate and thrive."
Ostwald has accepted an executive position within Freudenberg Group. He served Freudenberg Medical in various capacities for 16 years, doubling the division's annual revenue, expanding its global manufacturing footprint by one-third and integrating three joint ventures.
"Leading this extraordinary organization was an honor and a privilege," Ostwald said. "Michael is passionately committed to our strategy and values, developing our people and delivering high-quality products to improve patients' lives.
"I am convinced that Michael is the right leader to take Freudenberg Medical to the next level of success."
Ostwald's leadership was instrumental in shaping Freudenberg Medical's success, Sohi said.
"His strategic vision and dedication solidified the company's reputation as a trusted strategic partner in the medical device and pharmaceutical industries," he said.
McGee brings more than three decades of experience to the top post.
His appointment to CEO reflects Freudenberg's commitment to continuity, customer-centricity and alignment with the company's values, Sohi said.
"Since joining Freudenberg Medical, I have been deeply inspired by our company values and our talented global team with proven expertise in materials and technologies," McGee said. "Together, we will build on this strong foundation and drive meaningful advancements in health care.
"We remain steadfast in delivering consistent strategic partnership and prioritizing customer success."
Freudenberg Medical is a design for manufacturing firm for the medical device and biopharma industries.
The company has more than 2,800 associates across 11 global manufacturing sites in key medical technology hubs.
Freudenberg Group, with about $12.1 billion in annual sales, develops technologies, products and services for about 40 markets and for thousands of applications, including seals, vibration control components, technical textiles, filters, cleaning technologies and products, specialty chemicals and medical products.